RU2022101386A -
The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection)
- Google Patents
The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection)
Download PDF
Info
Publication number
RU2022101386A
RU2022101386ARU2022101386ARU2022101386ARU2022101386ARU 2022101386 ARU2022101386 ARU 2022101386ARU 2022101386 ARU2022101386 ARU 2022101386ARU 2022101386 ARU2022101386 ARU 2022101386ARU 2022101386 ARU2022101386 ARU 2022101386A
1. Применение лекарственного средства, содержащее в липосомах эффективное количество молекул РНКазы А, для профилактики или лечения коронавирусной инфекции, вызываемой SARS-CoV-2 для интраназального или ингаляционного введения.1. The use of a medicinal product containing an effective amount of RNase A molecules in liposomes for the prevention or treatment of coronavirus infection caused by SARS-CoV-2 for intranasal or inhalation administration.2. Применение комбинированного лекарственного средства, содержащее в липосомах эффективное количество молекул РНКазы А с никлозамидом, для профилактики или лечения коронавирусной инфекции, вызываемой SARS-CoV-2.2. The use of a combined drug containing in liposomes an effective amount of RNase A molecules with niclosamide for the prevention or treatment of coronavirus infection caused by SARS-CoV-2.3. Применение по п.2 для интраназального или ингаляционного введения.3. Use according to claim 2 for intranasal or inhalation administration.4. Способ профилактики или лечения SARS-CoV-2 инфекции, в котором молекулы РНКазы А с никлозамидом, содержащиеся в эффективном количестве в липосомах комбинированного лекарственного средства вводятся одновременно, отдельно или последовательно. 4. A method for preventing or treating SARS-CoV-2 infection, wherein RNase A molecules with niclosamide contained in an effective amount in liposomes of a combination drug are administered simultaneously, separately or sequentially.
RU2022101386A2022-01-21
The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection)
RU2022101386A
(en)
PROCEDURE FOR THE TREATMENT OF HUMAN DISEASES ASSOCIATED WITH A HIGH CONTENT OF DEOXIRRIBONUCLEIC ACID IN THE EXTRACELLULAR SPACES OF THE FABRICS AND MEDICAL PREPARATION TO CARRY OUT SUCH PROCEDURE.
Pharmaceutical composition, kit, use thereof and method for prophylactics and treatment of a symptom, condition or disease associated with infection by an influenza virus
The use of a drug having an antiviral effect for the prevention or treatment of SARS-CoV-2 coronavirus infection (variants) and a method for the prevention or treatment of SARS-CoV-2 (infection)